首页> 外文OA文献 >Fosamprenavir or atazanavir once daily boosted with ritonavir 100mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT

【2h】

Fosamprenavir or atazanavir once daily boosted with ritonavir 100mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT

机译：Fosamprenavir或atazanavir每日一次用ritonavir 100mg增强剂量，再加上tenofovir / emtricitabine加强治疗，最初用于HIV感染：ALERT 48周的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Kimberly Y Smith; Winkler G Weinberg; Edwin DeJesus; Margaret A Fischl; Qiming Liao; Lisa L Ross; Gary E Pakes; Keith A Pappa; C TRACEY Pakes;
展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT [J] . Kimberly Y Smith, Winkler G Weinberg, Edwin DeJesus, AIDS Research and Therapy . 2008,第1期

机译：Fosamprenavir或atazanavir每天一次用ritonavir 100 mg加强治疗，再加上tenofovir / emtricitabine进行HIV感染的初始治疗：ALERT 48周的结果
2. A randomized, double-blind comparison of coformulated elvitegravir/ cobicistat/emtricitabine/tenofovir DF vs ritonavir-boosted atazanavir plus coformulated emtricitabine and tenofovir DF for initial treatment of HIV-1 infection: Analysis of week 96 results [J] . RockstrohJ.K., DejesusE., HenryK., JAIDS: Journal of acquired immune deficiency syndromes . 2013,第5期

机译：联合配制的elvitegravir / cobicistat / emtricitabine / tenofovir DF与利托那韦增强的阿扎那韦联合配制的emtricitabine和tenofovir DF在HIV-1感染初始治疗中的随机，双盲比较：分析第96周的结果
3. Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: A randomised, double-blind, phase 3, non-inferiority trial [J] . DeJesusE., RockstrohJ.K., HenryK., The Lancet . 2012,第9835期

机译：共同制定的Elvitegravir，Cobicistat，Emtricistabine和Tenofovir Disoproxil富马酸葡萄球菌与Ritonavir-Boosted Atazanavir加上共同制定的Emtricicabine和Tenofovir Disoproxil Mumarate用于初始治疗HIV-1感染：随机，双盲，第3期，非劣级试验
4. Cost effectiveness analysis of abacavir/lamivudine versus tenofovir/emtricitabine combination therapy as part of highly active antiretroviral therapy in treatment naive HIV-infected patients. [D] . Giguere, Pierre. 2010

机译：阿巴卡韦/拉米夫定与替诺福韦/恩曲他滨联合疗法作为高活性抗逆转录病毒疗法治疗未受HIV感染的患者的成本效益分析。
5. Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg plus tenofovir/emtricitabine for the initial treatment of HIV infection: 48-week results of ALERT [O] . Kimberly Y Smith, Winkler G Weinberg, Edwin DeJesus, 2008

机译：Fosamprenavir或atazanavir每天一次用ritonavir 100 mg加强治疗再加上tenofovir / emtricitabine进行HIV感染的初始治疗：ALERT 48周的结果
6. Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT [O] . Smith, Kimberly Y, Weinberg, Winkler G, DeJesus, Edwin, 2008

机译：Fosamprenavir或atazanavir每天一次用ritonavir 100 mg加强治疗，再加上tenofovir / emtricitabine进行HIV感染的初始治疗：ALERT 48周的结果

Fosamprenavir or atazanavir once daily boosted with ritonavir 100mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT

著录项

相似文献

相关主题

期刊订阅